Zobrazeno 1 - 10
of 31
pro vyhledávání: '"CKJ Review"'
Publikováno v:
Clinical Kidney Journal
In haemodialysis (HD), unwanted substances (uraemic retention solutes or ‘uraemic toxins’) that accumulate in uraemia are removed from blood by transport across the semipermeable membrane. Like all membrane separation processes, the transport req
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66782fcd04b5c8bbc2cfa757ce479f45
http://europepmc.org/articles/PMC8711754
http://europepmc.org/articles/PMC8711754
Autor:
Bernard Canaud, Stefano Stuard, Frank Laukhuf, Grace Yan, Maria Ines Gomez Canabal, Paik Seong Lim, Michael A Kraus
Publikováno v:
Clinical Kidney Journal
The extent of removal of the uremic toxins in hemodialysis (HD) therapies depends primarily on the dialysis membrane characteristics and the solute transport mechanisms involved. While designation of ‘flux’ of membranes as well toxicity of compou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9696abc90e37b403c1087975b942d806
http://europepmc.org/articles/PMC8711767
http://europepmc.org/articles/PMC8711767
Autor:
Christian, Apel, Carsten, Hornig, Frank W, Maddux, Terry, Ketchersid, Julianna, Yeung, Adrian, Guinsburg
Publikováno v:
Clinical Kidney Journal
As the prevalence of chronic kidney disease is expected to rise worldwide over the next decades, provision of renal replacement therapy (RRT), will further challenge budgets of all healthcare systems. Most patients today requiring RRT are treated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05bff9a28320b420c5ec5158691ad0d
https://doi.org/10.1093/ckj/sfab193
https://doi.org/10.1093/ckj/sfab193
Publikováno v:
Clinical Kidney Journal
Hemodialysis (HD) is a life-sustaining therapy as well as an intermittent and repetitive stress condition for the patient. In ridding the blood of unwanted substances and excess fluid from the blood, the extracorporeal procedure simultaneously induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89cd03d038ff4f39bf58c6f8500899ca
https://doi.org/10.1093/ckj/sfab192
https://doi.org/10.1093/ckj/sfab192
Publikováno v:
Clinical Kidney Journal
Informed decision-making is paramount to the improvement of dialysis therapies and patient outcomes. A cornerstone of delivery of optimal dialysis therapy is to delineate which substances (uraemic retention solutes or ‘uraemic toxins’) contribute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7a5130ea4ca6615858e996c3037c0a
https://doi.org/10.1093/ckj/sfab202
https://doi.org/10.1093/ckj/sfab202
Publikováno v:
Clinical Kidney Journal
Haemodialysis (HD) utilizes the bidirectional properties of semipermeable membranes to remove uraemic toxins from blood while simultaneously replenishing electrolytes and buffers to correct metabolic acidosis. However, the nonspecific size-dependent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3758ea41a10abfd55f32ea74494df352
https://doi.org/10.1093/ckj/sfab183
https://doi.org/10.1093/ckj/sfab183
Autor:
Sudhir K, Bowry, Charles, Chazot
Publikováno v:
Clinical Kidney Journal
In most biological or industrial (including medical) separation processes, a membrane is a semipermeable barrier that allows or achieves selective transport between given compartments. In haemodialysis (HD), the semipermeable membrane is in a tubular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961a6035df9ec9a877f9dcdbe4f72147
https://doi.org/10.1093/ckj/sfab184
https://doi.org/10.1093/ckj/sfab184
Autor:
Lucio, Manenti, Emanuela, Leuci
Publikováno v:
Clinical Kidney Journal
Chronic kidney disease-associated pruritus (CKD-aP) is a potentially distressing condition that affects a significant proportion of patients with end-stage kidney disease undergoing dialysis. CKD-aP may lead to worsening of patients’ physical and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082f67703d0cf873f552201535b1aef3
https://doi.org/10.1093/ckj/sfab143
https://doi.org/10.1093/ckj/sfab143
Autor:
Dana Kim, Carol Pollock
Publikováno v:
Clinical Kidney Journal
Chronic kidney disease–associated pruritus (CKD-aP) is a common, yet underrecognized condition in patients with CKD and end-stage kidney disease (ESKD). Real-world observational studies indicate that CKD-aP affects up to 80% of ESKD patients underg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03aa80f566b622296fac8aefba67cc37
http://europepmc.org/articles/PMC8702817
http://europepmc.org/articles/PMC8702817
Publikováno v:
Clinical Kidney Journal
Chronic kidney disease (CKD)-associated pruritus (CKD-aP) is an underdiagnosed yet severely distressing condition that impacts 60% of patients on dialysis and many nondialysis patients with Stages 3–5 CKD. However, despite its high prevalence, ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12964bf92ede3782f58b56ca66007c6f
http://europepmc.org/articles/PMC8702820
http://europepmc.org/articles/PMC8702820